Cleared Traditional

BOEHRINGER MANNHEIM PRECINORM PRECIPATH PROTEIN CONTROLS (K981401) - FDA 510(k) Clearance

Class I Chemistry device.

K981401 · Boehringer Mannheim Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1998
Decision
31d
Days
Class 1
Risk

K981401 is an FDA 510(k) clearance for the BOEHRINGER MANNHEIM PRECINORM PRECIPATH PROTEIN CONTROLS. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Boehringer Mannheim Corp. (Indianapolis, US). The FDA issued a Cleared decision on May 18, 1998 after a review of 31 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boehringer Mannheim Corp. devices

Submission Details

510(k) Number K981401 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 1998
Decision Date May 18, 1998
Days to Decision 31 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 88d · This submission: 31d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 183
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K981401.
TUMOR MARKER CONTROL
K982473 · Diagnostic Products Corp. · Aug 1998
IMMULITE PSA CONTROL MODULE, MODEL LPSCM
K982637 · Diagnostic Products Corp. · Aug 1998
VIGIL PROTEIN CONTROL
K982224 · Beckman Coulter, Inc. · Jul 1998
THIRD GENERATION PSA CONTROL MODULE
K981455 · Diagnostic Products Corp. · May 1998
LYPHOCHEK IMMUNOASSAY PLUS CONTROL
K981532 · Bio-Rad · May 1998
BM PRECIPATH(R) HDL/LDL-C CONTROL
K974826 · Boehringer Mannheim Corp. · Jan 1998